15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $65M | -$19M | 12.1% | -25.6% | -103.9% | -29.2% | -$9M | $4M | $715674 |
| 2024 | $54M | -$16M | 7.9% | -28.6% | -66.0% | -29.8% | -$8M | $4M | $315105 |
| 2023 | $53M | -$19M | 8.1% | -40.9% | -51.4% | -28.1% | -$17M | $5M | — |
| 2022 | $50M | -$14M | 11.8% | -14.8% | -35.2% | -20.3% | -$15M | $5M | $21M |
| 2021 | $56M | -$8M | 14.8% | -8.1% | -181.8% | -16.1% | -$8M | $18M | $286487 |
| 2020 | $55M | $820786 | 14.5% | 4.9% | -19.7% | 1.9% | -$12M | $11M | $628395 |
| 2019 | $40M | -$3M | 9.2% | -0.6% | 51.1% | -13.8% | — | $0 | $38537 |
| 2018 | $37M | -$9M | 6.5% | -3.3% | 273.1% | -43.8% | -$2M | $145504 | $864343 |
| 2017 | $30M | -$6M | 6.5% | -16.2% | 205.1% | -58.2% | -$9M | — | $782853 |
| 2016 | $7M | -$601002 | 8.9% | -3.0% | 34.3% | -19.3% | -$2M | — | $716590 |
| 2015 | $533802 | -$7M | 9.2% | -82.9% | 536.0% | -1017.0% | -$541041 | — | $198049 |
| 2014 | $8M | $6M | 100.0% | 93.2% | 110.4% | 83.6% | $7M | — | $446604 |
| 2013 | $902369 | $246592 | 0.0% | 32.0% | -459.3% | 28.4% | — | — | $864489 |
| 2013 | — | -$344543 | — | — | 101.4% | -1829.2% | — | — | $18836 |
| 2013 | — | -$5M | — | — | 1559.4% | -74774.0% | — | — | $6143 |
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | $19M | -$6M | 8.0% | -15.4% | -29.4% | -9.9% | -$2M | $3M | $2M |
| Mar '26 | $18M | -$3M | 7.7% | -12.2% | -14.1% | -4.5% | -$1M | $3M | $514702 |
| Dec '25 | $20M | -$10M | 10.6% | -57.9% | -55.1% | -15.5% | -$5M | $4M | $715674 |
| Sep '25 | $17M | -$5M | 15.2% | -10.6% | -23.1% | -7.7% | -$2M | $5M | $889441 |
| Jun '25 | $15M | -$3M | 7.9% | -17.9% | -10.8% | -4.6% | -$1M | $5M | — |
| Mar '25 | $14M | -$818097 | 14.9% | -6.1% | -3.2% | -1.4% | -$198846 | $5M | — |
| Dec '24 | $14M | -$3M | 7.1% | -63.0% | -13.6% | -6.2% | -$4M | $4M | $315105 |
| Sep '24 | $12M | -$8M | 9.7% | -18.0% | -24.0% | -13.0% | $511007 | $4M | — |
| Jun '24 | $13M | -$3M | 5.8% | -18.9% | -8.1% | -4.3% | -$1M | $4M | — |
| Mar '24 | $15M | -$2M | 9.1% | -12.6% | -5.4% | -3.0% | -$3M | $4M | — |
| Dec '23 | $16M | -$14M | 7.8% | -85.8% | -38.2% | -20.8% | $905022 | $5M | — |
| Sep '23 | $13M | -$3M | 9.5% | -23.5% | -7.6% | -4.7% | -$5M | $4M | — |
| Jun '23 | $12M | -$981530 | 7.7% | -20.8% | -2.2% | -1.4% | -$7M | $3M | $2M |
| Mar '23 | $12M | -$459863 | 7.7% | -21.5% | -1.0% | -0.7% | -$6M | $4M | $12M |
| Dec '22 | $12M | -$11M | 3.6% | -60.6% | -27.5% | -15.9% | -$10M | $5M | $21M |
| Sep '22 | $12M | -$2M | 14.8% | -2.9% | -57.3% | -4.3% | -$2M | $14M | $312385 |
| Jun '22 | $13M | -$1M | 14.0% | -0.6% | -24.2% | -2.6% | -$713517 | $14M | $562320 |
| Mar '22 | $13M | $203347 | 14.5% | 1.9% | 4.1% | 0.4% | -$2M | $14M | $1M |
| Dec '21 | $16M | -$1M | 18.2% | -3.2% | -33.6% | -3.0% | -$2M | $18M | $286487 |
| Sep '21 | $14M | -$2M | 17.3% | -6.7% | -41.6% | -4.1% | -$4M | $3M | $1M |
How the market has priced COSM against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Cosmos Health Inc.'s revenue has grown 3.3% per year. These are computed facts, not advice.
As of FY2025, Cosmos Health Inc. reported $4M of total debt against $715674 of cash; operating income covered interest expense -8.8×.
In FY2025, gross margin was 12.1%, operating margin -25.6%, and net margin -29.3%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.